These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34663326)

  • 41. Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence.
    Puranik A; Lenehan PJ; Silvert E; Niesen MJM; Corchado-Garcia J; O'Horo JC; Virk A; Swift MD; Halamka J; Badley AD; Venkatakrishnan AJ; Soundararajan V
    medRxiv; 2021 Aug; ():. PubMed ID: 34401884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the Effectiveness and Safety of the BNT162b2 COVID-19 Vaccine in the Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
    Pascucci D; Nurchis MC; Sapienza M; Castrini F; Beccia F; D'Ambrosio F; Grossi A; Castagna C; Pezzullo AM; Zega M; Staiti D; De Simone FM; Mores N; Cambieri A; Vetrugno G; Damiani G; Laurenti P
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
    King ER; Towner E
    Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan.
    Saita M; Yan Y; Ito K; Sasano H; Seyama K; Naito T
    J Infect Chemother; 2022 Jan; 28(1):116-119. PubMed ID: 34580011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    Roest S; Hoek RAS; Manintveld OC
    N Engl J Med; 2021 May; 384(20):1968-1970. PubMed ID: 33882226
    [No Abstract]   [Full Text] [Related]  

  • 47. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    Barda N; Dagan N; Balicer RD
    N Engl J Med; 2021 May; 384(20):1970. PubMed ID: 33882227
    [No Abstract]   [Full Text] [Related]  

  • 49. Sociodemographic inequality in COVID-19 vaccination coverage among elderly adults in England: a national linked data study.
    Nafilyan V; Dolby T; Razieh C; Gaughan CH; Morgan J; Ayoubkhani D; Walker S; Khunti K; Glickman M; Yates T
    BMJ Open; 2021 Jul; 11(7):e053402. PubMed ID: 34301672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 Antibody Response to the BNT162b2 mRNA Vaccine in Persons with Past Natural Infection.
    Kang YM; Choe KW; Lee KD; Kim KN; Kim MJ; Lim J
    J Korean Med Sci; 2021 Sep; 36(35):e250. PubMed ID: 34490757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report.
    Bianchi FP; Germinario CA; Migliore G; Vimercati L; Martinelli A; Lobifaro A; Tafuri S; Stefanizzi P;
    J Infect Dis; 2021 Aug; 224(3):431-434. PubMed ID: 34007998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An assessment of the vaccination of school-aged children in England against SARS-CoV-2.
    Keeling MJ; Moore SE
    BMC Med; 2022 May; 20(1):196. PubMed ID: 35581585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study.
    Urakawa R; Isomura ET; Matsunaga K; Kubota K; Ike M
    BMC Infect Dis; 2022 Feb; 22(1):179. PubMed ID: 35197017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Development of thrombocytopenic purpura following BNT162b2 mRNA COVID-19 vaccination].
    Shibata K; Tanaka H; Otani A; Kubo M; Hasegawa A; Amano I
    Rinsho Ketsueki; 2021; 62(10):1519-1521. PubMed ID: 34732627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Development of autoimmune hemolytic anemia after BNT162b2 mRNA COVID-19 vaccination].
    Okuno S; Hashimoto K; Shimizu R; Takagi E; Kajiguchi T
    Rinsho Ketsueki; 2021; 62(10):1510-1514. PubMed ID: 34732625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020-17 May 2021): a population-level observational study.
    Tessier E; Rai Y; Clarke E; Lakhani A; Tsang C; Makwana A; Heard H; Rickeard T; Lakhani S; Roy P; Edelstein M; Ramsay M; Lopez-Bernal J; White J; Andrews N; Campbell CNJ; Stowe J
    BMJ Open; 2022 Mar; 12(3):e055278. PubMed ID: 35232787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Influenza Vaccination on the Response to BNT162b2 Messenger RNA COVID-19 Vaccine in Healthcare Workers.
    Greco M; Cucci F; Portulano P; Lazzari RA; Caldararo C; Sicuro F; Catanese C; Lobreglio G
    J Clin Med Res; 2021 Dec; 13(12):549-555. PubMed ID: 35059073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies.
    Chang S; Liu H; Wu J; Xiao W; Chen S; Qiu S; Duan G; Song H; Zhang R
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2.
    Di Fusco M; Moran MM; Cane A; Curcio D; Khan F; Malhotra D; Surinach A; Miles A; Swerdlow D; McLaughlin JM; Nguyen JL
    J Med Econ; 2021; 24(1):1248-1260. PubMed ID: 34844493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.